Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Cost effectiveness of prostate cancer radiotherapy.

08/06/2018
/ Publications
/
IMRT
Hypofractionation

This review article by Konski A, examined the data of cost-effectiveness analyses of various radiotherapy modalities including 3DCRT, IMRT, hypofractionated RT...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.

11/10/2017
/ Publications
/
Toxicity

This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.

The study demonstrated PBT...

Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.

11/11/2017
/ Publications
/
Hypofractionation

A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...

Biochemical Results, Toxicity, Patient QoL After Delivery of Dose-Escalated Image Guided PT for Prostate Cancer

01/02/2016
/ Publications
/
Toxicity

A large series of 1327 localized prostate cancer patients reported 5-year biochemical control rate, toxicity and patient-reported quality of life after proton...

PBT in rectal cancer

28/07/2021
/ Publications
/
Clinical Trial
PT101

This review article examined eight original studies with a total of 127 patients. There was significantly less irradiated small bowel with PBT compared to 3DCRT...

Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.

28/09/2021
/ Publications

A study by the Mayo Clinic group. This study examined the acute CTCAE reported by 55 patients (PRO-CTCAE) with high-risk or unfavorable intermediate-risk...

Is Proton Therapy for Prostate "Experimental"?

19/01/2022
/ Podcast

In this podcast we discuss the role of proton therapy for prostate cancer. It has been referred to as "experimental", but is showing to be increasingly...

Prostate Cancer

24/02/2023
/ Webinar

Jason Efstathiou gives an overview of protons for prostate cancer. He covers the clinical potential, the available and comparative data, and the future...

Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.

29/04/2024
/ Publications
/
IMRT

This study compared the bowel function (BF), urinary irritative/obstructive symptoms (UO), and urinary incontinence (UI) domains of EPIC-26 collected in 262...